Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis
- 376 Downloads
To evaluate the psychometric properties of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) and Visual Function Questionnaire Utility Index (VFQ-UI) in patients with non-infectious intermediate and posterior uveitis.
Secondary analysis of pooled data from a 26-week, multicenter, masked, randomized, sham-controlled Phase 3 clinical trial. Health-related quality of life was assessed using the NEI VFQ-25, the EQ-5D, and SF-36. Internal consistency reliability, reproducibility, convergent validity, and known groups of BCVA and vitreous haze severity were assessed. Clinically significant difference was assessed using anchor-based and distribution-based methods.
The study included 224 subjects with non-infectious intermediate (80.4 %) or posterior uveitis (19.6 %). The NEI VFQ-25 and the VFQ-UI demonstrated good internal consistency (Cronbach’s alpha 0.87–0.94) and test–retest reliability (ICCs 0.58–0.88). Spearman’s product–moment rank correlations between the NEI VFQ-25 and VFQ-UI scores and the SF-6D, EQ-5D, and BCVA ranged from small to moderate. There was a significant association between visual functioning and known groups of visual acuity (p < 0.05). Clinical significance, using the anchor-based method (difference between visual acuity groups ≥10–<15 letter better and no change), was 10.2 for change from baseline to week 26 for the NEI VFQ-25 composite score and 0.05 for the VFQ-UI. Using the distribution-based method, the clinical significance was 3.86 for the composite score and 0.04 for the VFQ-UI.
The NEI VFQ-25 and the VFQ-UI are reliable and valid measures of vision-related functioning and preference-based status in patients with non-infectious intermediate and posterior uveitis.
KeywordsOcular disease Vision-related functioning NEI VFQ-25 VFQ-UI Uveitis Psychometric evaluation
- 2.Markomichelakis, N. N., Halkiadakis, I., Pantelia, E., Peponis, V., Patelis, A., Theodossiadis, P., et al. (2004). Patterns of macular edema in patients with uveitis: Qualitative and quantitative assessment using optical coherence tomography. Ophthalmology, 111(5), 946–953.PubMedCrossRefGoogle Scholar
- 6.Rentz, A. M., Kowalski, J. W., Walt, J., Hays, R. D., Brazier, J. E., Yu, R., Lee, P., Bressler, N. M., & Revicki, D. A. (submitted.). Developing a preference-based single index for the National Eye Institute Visual Function Questionnaire-25. Arch Opth.Google Scholar
- 7.Kowalski, J. W., Rentz, A. M., Walt, J., Lloyd, A., Young, D., Chen, W. H., Bressler, N. M., Lee, P., Brazier, J. E., Hays, R. D., & Revicki, D. A. (2011). Development of a classification system for health states from the National Eye Institute Visual Function Questionnaire-25. Quality of life research. August 04, 2011. (Epub ahead of print).Google Scholar
- 8.Ware, J. E., Kosinski, M., & Keller, S. D. (1994). SF-36 physical and mental health summary scales: A users manual. Boston: The Health Institute.Google Scholar
- 14.Hays, R. D., & Revicki, D. (2005). Reliability and validity (including responsiveness). In P. Fayers & R. D. Hays (Eds.), Assessing quality of life in clinical trials (2nd ed., pp. 25–40). New York: Oxford University Press.Google Scholar
- 21.Frick, K. D., Drye, L. T., Kempen, J. H., Dunn, J. P., Holland, G. N., Latkany, P., et al. (2012). Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Investigative Ophthalmology and Visual Science, 53, 1169–1176.PubMedCrossRefGoogle Scholar
- 22.Nussenblatt, R. B., & Whitcup, S. M. (2004). Uveitis: Fundamentals and clinical practice (3rd ed.). St. Louis: Mosby.Google Scholar